Actively Recruiting
Pregnancy and Postpartum CGM in GDM
Led by Icahn School of Medicine at Mount Sinai · Updated on 2025-09-15
40
Participants Needed
1
Research Sites
53 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose monitor data from the third trimester and up to 14 days postpartum to find predictors of postpartum OGTT results.
CONDITIONS
Official Title
Pregnancy and Postpartum CGM in GDM
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of gestational diabetes during current pregnancy
- Age 18 or older
- Prescribed Dexcom G7 continuous glucose monitor
You will not qualify if you...
- Pregestational diabetes
- Known skin adhesive allergy preventing use of continuous glucose monitor
- Chronic oral steroid use
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029
Actively Recruiting
Research Team
S
Shaziah Hassan
CONTACT
G
Grenye O'Malley
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here